A pilot study of glioblastoma multiforme in elderly patients: Treatments, O-6-methylguanine-DNA methyltransferase (MGMT) methylation status and survival

Clinical Neurology and Neurosurgery

Volumn 115, Issue 8, 2013, Pages 1375-1378

  Abhinav, K ^a   Aquilina, K ^a   Gbejuade, H ^a   La, M ^a   Hopkins, K ^a   Iyer, V ^a  

^a FRENCHAY HOSPITAL   (United Kingdom)

Author keywords

Elderly; Glioblastoma multiforme; Methylated; MGMT; Survival; Unmethylated temozolamide

Indexed keywords

METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE; TEMOZOLOMIDE;

AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER MORTALITY; CANCER RADIOTHERAPY; CHEMORADIOTHERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; DNA METHYLATION; FEMALE; GLIOBLASTOMA; HUMAN; MALE; OVERALL SURVIVAL; PILOT STUDY; RISK; UNITED KINGDOM; WORLD HEALTH ORGANIZATION;

ELDERLY; GLIOBLASTOMA MULTIFORME; METHYLATED; MGMT; SURVIVAL; UNMETHYLATED TEMOZOLAMIDE;

AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; BIOPSY; BRAIN NEOPLASMS; CHEMORADIOTHERAPY; COHORT STUDIES; COMBINED MODALITY THERAPY; DACARBAZINE; FEMALE; GLIOBLASTOMA; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; NEUROSURGICAL PROCEDURES; O(6)-METHYLGUANINE-DNA METHYLTRANSFERASE; PILOT PROJECTS; PROGNOSIS; SURVIVAL; TREATMENT OUTCOME;

EID: 84880325944     PISSN: 03038467     EISSN: 18726968     Source Type: Journal    
DOI: 10.1016/j.clineuro.2012.12.023     Document Type: Article

References (34)

1. P.Y. Wen, H.A. Fine, P.M. Black, D.C. Shrieve, E. Alexander III, and J.S. Loeffler High-grade astrocytomas Neurologic Clinics 13 1995 875 900
2. M.J. McGirt, K.D. Than, J.D. Weingart, K.L. Chaichana, F.J. Attenello, and A. Olivi Gliadel (BCNU) wafer plus concomitant temozolomide therapy after primary resection of glioblastoma multiforme Journal of Neurosurgery 110 2009 583 588
3. N. Sanai, and M.S. Berger Glioma extent of resection and its impact on patient outcome Neurosurgery 62 2008 753 764
4. C. Ewelt, M. Goeppert, M. Rapp, H.J. Steiger, W. Stummer, and M. Sabel Glioblastoma multiforme of the elderly: the prognostic effect of resection on survival Journal of Neuro-Oncology 103 2011 611 618
5. I. Chakrabarti, M. Cockburn, W. Cozen, Y.P. Wang, and S. Preston-Martin A population-based description of glioblastoma multiforme in Los Angeles County, 1974-1999 Cancer 104 2005 2798 2806
6. M.W. Gross, R. Altscher, M. Brandtner, H. Haeusser-Mischlich, I.C. Chiricuta, and A.D. Siegmann Open-label simultaneous radio-chemotherapy of glioblastoma multiforme with topotecan in adults Clinical Neurology and Neurosurgery 107 2005 207 213
7. M. Hutterer Elderly patients with glioblastoma multiforme - an underestimated subpopulation? Neuroepidemiology 33 2009 23 24
8. F.M. Iwamoto, L.E. Abrey, K. Beal, P.H. Gutin, M.K. Rosenblum, and V.E. Reuter Patterns of relapse and prognosis after bevacizumab failure in recurrent glioblastoma Neurology 73 2009 1200 1206
9. F.M. Iwamoto, A.R. Cooper, A.S. Reiner, L. Nayak, and L.E. Abrey Glioblastoma in the elderly: the Memorial Sloan-Kettering Cancer Center Experience (1997-2007) Cancer 115 2009 3758 3766
10. M. Wrensch, Y. Minn, T. Chew, M. Bondy, and M.S. Berger Epidemiology of primary brain tumors: current concepts and review of the literature Neuro-Oncology 4 2002 278 299
11. K.L. Chaichana, K.K. Chaichana, A. Olivi, J.D. Weingart, R. Bennett, and H. Brem Surgical outcomes for older patients with glioblastoma multiforme: preoperative factors associated with decreased survival Journal of Neurosurgery 114 2011 587 594
12. K.L. Chaichana, T. Garzon-Muvdi, S. Parker, J.D. Weingart, A. Olivi, and R. Bennett Supratentorial glioblastoma multiforme: the role of surgical resection versus biopsy among older patients Annals of Surgical Oncology 18 2011 239 245
13. M.E. Hegi, A.C. Diserens, T. Gorlia, M.F. Hamou, N. de Tribolet, and M. Weller MGMT gene silencing and benefit from temozolomide in glioblastoma New England Journal of Medicine 352 2005 997 1003
14. E.R. Gerstner, S. Yip, D.L. Wang, D.N. Louis, A.J. Iafrate, and T.T. Batchelor MGMT methylation is a prognostic biomarker in elderly patients with newly diagnosed glioblastoma Neurology 73 2009 1509 1510
15. X.C. Qian, and T.P. Brent Methylation hot spots in the 5′ flanking region denote silencing of the O6-methylguanine-DNA methyltransferase gene Cancer Research 57 1997 3672 3677
16. G.S. Watts, R.O. Pieper, J.F. Costello, Y.M. Peng, W.S. Dalton, and B.W. Futscher Methylation of discrete regions of the O6-methylguanine DNA methyltransferase (MGMT) CpG island is associated with heterochromatinization of the MGMT transcription start site and silencing of the gene Molecular and Cellular Biology 17 1997 5612 5619
17. G.M. Ciocco, R.C. Moschel, M.Y. Chae, P.J. McLaughlin, I.S. Zagon, and A.E. Pegg Specific labeling of O6-alkylguanine-DNA alkyltransferase by reaction with O6-(p-hydroxy[3H]methylbenzyl)guanine Cancer Research 55 1995 4085 4091
18. M.E. Hegi, L. Liu, J.G. Herman, R. Stupp, W. Wick, and M. Weller Correlation of O6-methylguanine methyltransferase (MGMT) promoter methylation with clinical outcomes in glioblastoma and clinical strategies to modulate MGMT activity Journal of Clinical Oncology 26 2008 4189 4199
19. M. Hermisson, A. Klumpp, W. Wick, J. Wischhusen, G. Nagel, and W. Roos O6-methylguanine DNA methyltransferase and p53 status predict temozolomide sensitivity in human malignant glioma cells Journal of Neurochemistry 96 2006 766 776
20. P.G. Corn, S.J. Kuerbitz, M.M. van Noesel, M. Esteller, N. Compitello, and S.B. Baylin Transcriptional silencing of the p73 gene in acute lymphoblastic leukemia and Burkitt's lymphoma is associated with 5′ CpG island methylation Cancer Research 59 1999 3352 3356
21. M. Esteller, S.R. Hamilton, P.C. Burger, S.B. Baylin, and J.G. Herman Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is a common event in primary human neoplasia Cancer Research 59 1999 793 797
22. K.L. Chaichana, K.K. Chaichana, A. Olivi, J.D. Weingart, R. Bennett, and H. Brem Surgical outcomes for older patients with glioblastoma multiforme: preoperative factors associated with decreased survival Journal of Neurosurgery 114 2011 587 594 [Clinical article]
23. F. Laigle-Donadey, and J.Y. Delattre Glioma in the elderly Current Opinion in Oncology 18 2006 644 647
24. C.A. Marijnen, S.M. van den Berg, S.G. van Duinen, J.H. Voormolen, and E.M. Noordijk Radiotherapy is effective in patients with glioblastoma multiforme with a limited prognosis and in patients above 70 years of age: a retrospective single institution analysis Radiotherapy and Oncology 75 2005 210 216
25. A.A. Brandes, A. Compostella, V. Blatt, and A. Tosoni Glioblastoma in the elderly: current and future trends Critical Reviews in Oncology/Hematology 60 2006 256 266
26. A.A. Brandes, E. Franceschi, A. Tosoni, F. Benevento, L. Scopece, and V. Mazzocchi Temozolomide concomitant and adjuvant to radiotherapy in elderly patients with glioblastoma: correlation with MGMT promoter methylation status Cancer 115 2009 3512 3518
27. R.J. Kimple, S. Grabowski, M. Papez, F. Collichio, M.G. Ewend, and D.E. Morris Concurrent temozolomide and radiation, a reasonable option for elderly patients with glioblastoma multiforme? American Journal of Clinical Oncology 33 2010 265 270
28. R. Stupp, W.P. Mason, M.J. van den Bent, M. Weller, B. Fisher, and M.J. Taphoorn Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma New England Journal of Medicine 352 2005 987 996
29. H.A. Fine, K.B. Dear, J.S. Loeffler, P.M. Black, and G.P. Canellos Meta-analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults Cancer 71 1993 2585 2597
30. J. Perry, N. Laperriere, L. Zuraw, A. Chambers, K. Spithoff, and J.G. Cairncross Adjuvant chemotherapy for adults with malignant glioma: a systematic review Canadian Journal of Neurological Sciences 34 2007 402 410
31. M. Piccirilli, S. Bistazzoni, F.M. Gagliardi, A. Landi, A. Santoro, and F. Giangaspero Treatment of glioblastoma multiforme in elderly patients. Clinico-therapeutic remarks in 22 patients older than 80 years Tumori 92 2006 98 103
32. C. Ang, M.C. Guiot, A.V. Ramanakumar, D. Roberge, and P. Kavan Clinical significance of molecular biomarkers in glioblastoma Canadian Journal of Neurological Sciences 37 2010 625 630
33. B.M. Costa, C. Caeiro, I. Guimaraes, O. Martinho, T. Jaraquemada, and I. Augusto Prognostic value of MGMT promoter methylation in glioblastoma patients treated with temozolomide-based chemoradiation: a Portuguese multicentre study Oncology Reports 23 2010 1655 1662
34. A. Malmstrom, B.H. Gronberg, C. Marosi, R. Stupp, D. Frappaz, and H. Schultz Temozolomide versus standard 6-week radiotheraphy versus hypofractionated radiotherapy in patients older than 60 years with glioblastoma: the Nordic randomised, phase 3 trial Lancet Oncology 13 2012 916 926